OptimizeRx (OPRX) Retained Earnings (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Retained Earnings data on file, last reported at $209.3 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 3.21% year-over-year to $209.3 million; the trailing twelve-month figure through Mar 2026 stood at $209.3 million (up 3.21% YoY), and the FY2025 full-year result was -$79.2 million, up 6.08% from the prior year.
• Retained Earnings grew to $209.3 million in Q1 2026, from -$79.2 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $209.3 million in Q1 2026 to a low of -$84.4 million in Q4 2024.
• A 5-year average of $86.5 million and a median of $176.2 million in 2023 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings jumped 611.45% in 2022 and sank 147.84% in 2024, its largest moves.
• Tracing OPRX's Retained Earnings over 5 years: stood at -$46.7 million in 2022, then sank by 37.62% to -$64.3 million in 2023, then plunged by 31.3% to -$84.4 million in 2024, then climbed by 6.08% to -$79.2 million in 2025, then soared by 364.18% to $209.3 million in 2026.
• Business Quant data shows OPRX's Retained Earnings at $209.3 million in Q1 2026, -$79.2 million in Q4 2025, and $206.5 million in Q3 2025.